1986
DOI: 10.1016/0378-5173(86)90134-1
|View full text |Cite
|
Sign up to set email alerts
|

Physostigmine emulsion: a new injectable controlled release delivery system

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
16
0

Year Published

1988
1988
2015
2015

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 41 publications
(16 citation statements)
references
References 17 publications
0
16
0
Order By: Relevance
“…Moreover, the incorporation of certain drugs in an emulsion formulation with phospholipids as sole emulsifier has been found to reduce stability and cause phase separation [5]. The combination of phospholipids and poloxamer as an emulsifying complex was found to increase emulsion stability, probably because of the formation of a complex interfacial film between poloxamer and the phospholipid molecules at the oilwater interface [6].…”
Section: Introductionmentioning
confidence: 99%
“…Moreover, the incorporation of certain drugs in an emulsion formulation with phospholipids as sole emulsifier has been found to reduce stability and cause phase separation [5]. The combination of phospholipids and poloxamer as an emulsifying complex was found to increase emulsion stability, probably because of the formation of a complex interfacial film between poloxamer and the phospholipid molecules at the oilwater interface [6].…”
Section: Introductionmentioning
confidence: 99%
“…The charge on emulsion droplets was measured using the moving boundary electrophoresis technique. The shape of the electrophoresis cell and the manner of converting elec trophoretic mobility to zeta potential has been dis cussed in detail in previous works [7,8].…”
Section: Emulsion Evaluationmentioning
confidence: 99%
“…We have investigated innovative submi cron-medicated emulsions for several years, mainly as vehicles for lipophilic drugs [7][8][9], A possible use of these emulsions as vehicles for a lipophilic ophthalmic drug such as A8-tetrahydrocannabinol (A8-THC) appeared of interest.…”
Section: Introductionmentioning
confidence: 99%
“…the inability to provide sustained release of the drugs incorporated in oily droplets. [25,26] These colloidal vectors are prepared with lipids in solid state at room temperature, thus the drug mobility inside the nanoparticles is considerably decreased compared to liquid droplets. [27] SLNs can be prepared with multiple methods such as high shear homogenization and ultrasounds, [28] high pressure homogenization, [29,30] hot homogenization, [31] cold homogenization, [32] and emulsification/solvent evaporation.…”
Section: Introductionmentioning
confidence: 99%